The preparation of S-2-Hydroxy-3-methoxy-3,3-diphenylpropionic acid is described in WO 9611914; eidem, U.S. Pat. No. 5,932,730 (1996, 1998 both to BASF) and in J. Med. Chem., 1996, vol. 39, No. 11, p. no. 2123-2128
In WO9611914 the following route is described (Scheme-1):
Benzophenone is reacted with methyl chloroacetate in presence of sodium methoxide base. The product after work up is treated with p-toluene sulfonic acid and is hydrolysed with sodium hydroxide solution to yield 2-Hydroxy-3-methoxy -3,3-diphenyl propionic acid
(S)-1-(4-nitrophenyl)ethylamine is added to 2-hydroxy-3-methoxy-3,3-diphenylpropionic acid in acetone and methyl tert-butyl ether under reflux, the mixture was seeded, boiled under reflux for one hour after cooling to RT The crystals (S-2-hydroxy-3-methoxy-3,3-diphenylpropionic acid salt of (S)-1-(4-nitrophenyl)ethylamine were filtered off. The salt is acidified and liberated compound of formula (I) is extracted into solvent. Solvent is distilled off to give compound of formula (I)
The following are the observations after implementing the above mentioned process in lab
Step-I is one pot reaction involving three reactions epoxidation, rearrangement and hydrolysis. It does not yield pure product and is contaminated with all the starting materials and byproducts and number of purification steps are required to get pure product.
This resolution stage is reported with resolving agents L-proline methyl ester and (S)-1-(4-nitrophenyl)ethylamine. L-proline methyl ester has not been worked out for resolution. After resolution with (S)-1-(4-nitrophenyl)ethylamine the yield of S-2-hydroxy-3-methoxy-3,3-diphenylpropionic acid is 15% with 0.5% enantiomeric impurity.
In the procedure discussed in J. Med. Chem., 1996, vol. 39, No. 11, stage-I is split into three steps as shown below (Scheme-II). In this paper the resolution of 2-hydroxy-3-methoxy-3,3-diphenyl propionic acid (II) is not mentioned.
Taking into consideration the above mentioned shortcomings of the preparation of the compound of the formula I, our aim was directed towards developing an improved environmentally safe and industrially applicable process, which is devoid of the insufficiencies of the known method synthesis of pure desired compound (I) in high yields.
Therefore the main objective of the present invention is to provide an improved process for the preparation of Ambrisentan precursor S-2-hydroxy-3-methoxy-3,3-diphenylpropionic acid of the formula (I) avoiding the drawbacks of the hitherto known processes.
Another objective of the present invention is to provide an improved process for the preparation of Methyl 3,3-diphenyl 2,3-epoxy propionate of the formula (II)
Yet another objective of the present invention is to provide an improved process for the preparation of methyl-2-hydroxy-3-methoxy-3,3-diphenyl propionate of the formula (III)
Still another objective of the present invention is to provide an improved process for the preparation of 2-Hydroxy-3-methoxy-3,3-diphenyl propionic acid of the formula (IV)
Accordingly, the present invention provides an improved method for the preparation of Methyl 3,3-diphenyl 2,3-epoxy propionate of the formula-(II)—which comprises
Accordingly, the present invention provides an improved method for the preparation of methyl-2-hydroxy-3-methoxy-3,3-diphenyl propionate of the formula-(III) which comprises
Accordingly, the present invention provides an improved method for the preparation of 2-hydroxy-3-methoxy-3,3-diphenyl propionic acid of the formula-(IV) which comprises
Accordingly, the present invention provides an improved method for the preparation of S-2-hydroxy-3-methoxy-3,3-diphenyl propionic acid of the formula-(I) which comprises
The solid state properties of S-2-hydroxy-3-methoxy-3,3-diphenyl propionic acid of the formula-(I) thus prepared are illustrated by the following figures:
FIG. 1—XRPD spectrum of the compound of the formula-I prepared by the method disclosed in example-1
FIG. 2—DSC curve of the compound of the formula-I prepared by the method disclosed in example-1
FIG. 3—IR spectrum of the compound of the formula-I prepared by the method disclosed in example-1
The details of the inventions are given in the Examples which are provided for illustration only and therefore the Examples should not be construed to limit the scope of the invention.
Process for the Preparation S-2-Hydroxy-3-methoxy-3,3-diphenyl propionic acid of the Formula-I
Into a 5 L round bottomed flask a mixture of toluene (1.2 L) and benzophenone (500 g) were charged and stirred for 15 minutes. Sodium methoxide (260 g) was charged and the reaction mixture stirred for 15 minutes. Reaction mass was cooled to −5 to −10° C. and methyl chloro acetate (506.3 g dissolved in 0.3 L toluene) was added slowly during 90 minutes at the same temperature. Reaction mass was maintained at the same temperature and purified water (1 L) was added. Reaction mass was stirred for 1 hour and toluene layer was separated. Toluene layer was distilled of completely under vacuum. The residual compound II was taken for next step.
Yield: 660 g (94.8%)
Purity by HPLC: 95.5% (benzophenone content: 4%)
Into a 5 L round bottomed flask a mixture of methanol (1.2 L) and compound of formula-I (660 g) from the previous step were charged and stirred for 15 minutes. p-Toluene sulphonic acid (15 g dissolved in 150 ml methanol) was slowly added during 30 minutes at 25-55° C. The reaction mass was brought to room temperature, maintained at the same temperature for 2 hours was filtered and the filtered compound was dissolved in ethyl acetate (3 L). Ethyl acetate layer was washed with 5% sodium bicarbonate solution (2×1 L). Ethyl acetate layer was distilled off completely under vacuum. To the residue hexane (1L) was charged and maintained under stirring for 2 hours. The product was filtered and dried at 50-60° C.
Dry weight: 560 g (75%)
Purity by HPLC: 99.9%
Melting range: 100-102° C.
Into a 5 L round bottomed flask a mixture water (1.0 L) and compound of formula-III (200 g) from step-II were charged and stirred for 15 minutes. 1N aqueous sodium hydroxide solution was charged and the reaction mass was stirred for 15 minutes. Reaction mass was heated to 90-95° C. and maintained at the same temperature for one hour. The reaction mass was brought to room temperature adjustment of pH was carried out with 1N hydrochloric acid solution (1.6 L) to 2-3. The product slurry was cooled to 5-10° C. and maintained at the same temperature for 2 hours. The product was filtered and dried at 60-65° C.
Dry weight: 172 g (90%)
Purity by HPLC: 99.88%
Melting range: 100-102° C.
Into a 3 L round bottomed flask compound of formula (IV) from step-III (200 g) was added to a mixture methyl tert-butyl ether (1.25 L) and acetone (1.5 L). Reaction mass was heated to reflux temperature (50-55° C.) and S-(-)p-nitro phenyl ethyl amine (61 g dissolved in 250 ml of MTB) was added slowly during 30 minutes at reflux temperature. Reaction mass was maintained at the same temperature for one hour and cooled to 10-15° C. and maintained at the same temperature for 12 hours. It was filtered and washed with MTB (500 ml). The wet diastereomeric salt was suspended in a mixture of MTB (500 ml) and water (1.5 L) and acidified with concentrated hydrochloric acid (30 ml). the resulting mixture was stirred for 30 minutes and the organic layer was separated.
Aqueous layer was extracted with MTB (500 ml) and the combined MTB layer was washed with water and distilled completely under vacuum. Reaction mass was brought to 40° C. and mixture of MTB (138 ml) and n-heptane (322 ml) were charged and the cooled to 25-30° C. The crystalline compound of formula-I was filtered and dried at 50-60° C.
Dry weight: 55 g (55%)
Purity by HPLC: 99.97% (chemical purity)
Melting range: 123-125° C.
1) S-2-Hydroxy-3-methoxy-3,3-diphenyl propionic acid is produced in more than 99.8% chemical purity.
2) The chiral purity of S-2-Hydroxy-3-methoxy-3,3-diphenyl propionic acid by the process of the present invention is about 99.9%
3) S-2-Hydroxy-3-methoxy-3,3-diphenyl propionic acid prepared by this method is suitable for synthesis of pharmaceutical grade Ambrisentan.
Filing Document | Filing Date | Country | Kind | 371c Date |
---|---|---|---|---|
PCT/IN10/00519 | 8/4/2010 | WO | 00 | 3/25/2013 |